Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danirixin in Acute Uncomplicated Influenza
NCT02469298Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2015
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of danirixin in influenza, sponsored by GSK. Started Jun 2015; status: completed.
02
Drugs
danirixin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02469298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469298.